On the public citation graph
Using NMR Spectroscopy in the Fragment‐Based Drug Discovery of Small‐Molecule Anticancer Targeted Therapies
0 signed · 203 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/(sici)1098-1128(199601)16:1<3::aid-med1>3.0.co;2-6openalex-snapshot
The art and practice of structure-based drug design: A molecular modeling perspective
inferredcites →https://doi.org/10.1002/(sici)1521-3757(19990614)111:12<1902::aid-ange1902>3.0.co;2-oopenalex-snapshot
Charakterisierung von Ligandenbindung durch Sättigungstransfer-Differenz-NMR-Spektroskopie
inferredcites →https://doi.org/10.1002/(sici)1521-3773(19990115)38:1/2<98::aid-anie98>3.0.co;2-vopenalex-snapshot
Bioaffinity NMR Spectroscopy: Identification of an E-Selectin Antagonist in a Substance Mixture by Transfer NOE
inferredcites →https://doi.org/10.1002/(sici)1521-3773(19990614)38:12<1784::aid-anie1784>3.0.co;2-qopenalex-snapshot
Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy
inferredcites →https://doi.org/10.1002/1439-7633(20020301)3:2/3<167::aid-cbic167>3.0.co;2-sopenalex-snapshot
Spin Labels as a Tool to Identify and Characterize Protein-Ligand Interactions by NMR Spectroscopy
inferredcites →https://doi.org/10.1002/ange.200390202openalex-snapshot
NMR‐Techniken zum Screening und zur Identifizierung der Bindung von Liganden an Proteinrezeptoren
inferredcites →https://doi.org/10.1002/anie.200390233openalex-snapshot
NMR Spectroscopy Techniques for Screening and Identifying Ligand Binding to Protein Receptors
inferredcites →https://doi.org/10.1002/chem.200500636openalex-snapshot
SAR by ILOEs: An NMR‐Based Approach to Reverse Chemical Genetics
inferredcites →https://doi.org/10.1002/chem.202000584openalex-snapshot
Library Design Strategies To Accelerate Fragment‐Based Drug Discovery
inferredcites →https://doi.org/10.1002/cmr.a.20121openalex-snapshot
Theoretical analysis of the competition ligand‐based NMR experiments and selected applications to fragment screening and binding constant measurements
inferredcites →https://doi.org/10.1002/cphc.201300219openalex-snapshot
Studying the Structure and Dynamics of Biomolecules by Using Soluble Paramagnetic Probes
inferredcites →https://doi.org/10.1002/cphc.201701253openalex-snapshot
Investigating Protein–Ligand Interactions by Solution Nuclear Magnetic Resonance Spectroscopy
inferredcites →https://doi.org/10.1002/ijc.10096openalex-snapshot
Upregulation of bcl‐2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines
inferredcites →https://doi.org/10.1006/jmre.1999.1897openalex-snapshot
Theoretical Analysis of the Inter-Ligand Overhauser Effect: A New Approach for Mapping Structural Relationships of Macromolecular Ligands
inferredcites →https://doi.org/10.1007/128_2011_183openalex-snapshot
Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors
inferredcites →https://doi.org/10.1007/978-1-4939-2486-8openalex-snapshot
Fragment-Based Methods in Drug Discovery
inferredcites →https://doi.org/10.1007/978-1-4939-2486-8_7openalex-snapshot
Site Identification by Ligand Competitive Saturation (SILCS) Simulations for Fragment-Based Drug Design
inferredcites →https://doi.org/10.1007/978-1-60761-931-4_12openalex-snapshot
Fragment-Based Drug Design
inferredcites →https://doi.org/10.1007/978-3-662-05314-0_2openalex-snapshot
Target Analysis: A Priori Assessment of Druggability
inferredcites →https://doi.org/10.1007/978-981-15-1025-0_18openalex-snapshot
Targeting Protein Neddylation for Cancer Therapy
inferredcites →https://doi.org/10.1007/978-981-15-1025-0_9openalex-snapshot
Targeting SCF E3 Ligases for Cancer Therapies
inferredcites →https://doi.org/10.1007/s00216-003-2410-3openalex-snapshot
Analytical applications of NMR diffusion measurements
inferredcites →https://doi.org/10.1007/s00280-008-0697-7openalex-snapshot
Inducing apoptosis and enhancing chemosensitivity to Gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell
inferredcites →https://doi.org/10.1007/s10822-009-9280-5openalex-snapshot
Lessons for fragment library design: analysis of output from multiple screening campaigns
inferredcites →https://doi.org/10.1007/s10858-009-9310-6openalex-snapshot
CPMG relaxation dispersion NMR experiments measuring glycine 1Hα and 13Cα chemical shifts in the ‘invisible’ excited states of proteins
inferredcites →https://doi.org/10.1007/s10858-013-9740-zopenalex-snapshot
Fragment-based drug discovery using NMR spectroscopy
inferredcites →https://doi.org/10.1007/s10858-019-00276-yopenalex-snapshot
Revisiting 1HN CPMG relaxation dispersion experiments: a simple modification can eliminate large artifacts
inferredcites →https://doi.org/10.1007/s10858-019-00279-9openalex-snapshot
NMR-based fragment screening and lead discovery accelerated by principal component analysis
inferredcites →https://doi.org/10.1007/s12029-019-00272-3openalex-snapshot
Molecular Genetics and the Role of Molecularly Targeted Agents in Metastatic Colorectal Carcinoma
inferredcites →https://doi.org/10.1007/s12551-016-0221-yopenalex-snapshot
NMR magnetization-transfer analysis of rapid membrane transport in human erythrocytes
inferredcites →https://doi.org/10.1007/s40265-020-01304-0openalex-snapshot
New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma
inferredcites →https://doi.org/10.1007/s40272-019-00369-zopenalex-snapshot
Molecularly Targeted Agents in the Therapy of Pediatric Brain Tumors
inferredcites →https://doi.org/10.1016/0006-291x(80)90695-6openalex-snapshot
A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules
inferredcites →https://doi.org/10.1016/0079-6565(94)80015-4openalex-snapshot
Recent developments in transferred NOE methods
inferredcites →https://doi.org/10.1016/j.bbamcr.2003.08.009openalex-snapshot
The role of Bcl-2 family members in tumorigenesis
inferredcites →https://doi.org/10.1016/j.bcp.2017.02.022openalex-snapshot
Identification of novel B-RafV600E inhibitors employing FBDD strategy
inferredcites →https://doi.org/10.1016/j.bmcl.2007.05.038openalex-snapshot
The role of molecular size in ligand efficiency
inferredcites →https://doi.org/10.1016/j.bmcl.2014.02.010openalex-snapshot
Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein
inferredcites →https://doi.org/10.1016/j.cbpa.2011.05.008openalex-snapshot
Molecular complexity and fragment-based drug discovery: ten years on
inferredcites →https://doi.org/10.1016/j.ccr.2006.10.006openalex-snapshot
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia
inferredcites →https://doi.org/10.1016/j.ccr.2013.01.018openalex-snapshot
ABT-199: Taking Dead Aim at BCL-2
inferredcites →https://doi.org/10.1016/j.chembiol.2004.12.004openalex-snapshot
TINS, Target Immobilized NMR Screening: An Efficient and Sensitive Method for Ligand Discovery
inferredcites →https://doi.org/10.1016/j.ddtec.2010.11.012openalex-snapshot
Surface Plasmon Resonance biosensor analysis as a useful tool in FBDD
inferredcites →https://doi.org/10.1016/j.drudis.2019.12.006openalex-snapshot
Fragment-based drug discovery using cryo-EM
inferredcites →https://doi.org/10.1016/j.drudis.2020.01.014openalex-snapshot
Frequent hitters: nuisance artifacts in high-throughput screening
inferredcites →https://doi.org/10.1016/j.drudis.2020.06.023openalex-snapshot
The rise of molecular simulations in fragment-based drug design (FBDD): an overview
inferredcites →https://doi.org/10.1016/j.ejmech.2016.09.098openalex-snapshot
Fragment-based discovery of novel pentacyclic triterpenoid derivatives as cholesteryl ester transfer protein inhibitors
inferredcites →https://doi.org/10.1016/j.path.2019.11.002openalex-snapshot
Targeted Therapy and Checkpoint Immunotherapy in Lung Cancer
inferredcites →https://doi.org/10.1016/j.pbiomolbio.2014.08.012openalex-snapshot
NMR approaches in structure-based lead discovery: Recent developments and new frontiers for targeting multi-protein complexes
inferredcites →https://doi.org/10.1016/j.pharmthera.2014.08.003openalex-snapshot
Small molecule Mcl-1 inhibitors for the treatment of cancer
inferredcites →https://doi.org/10.1016/j.pharmthera.2016.07.003openalex-snapshot
The ways and means of fragment-based drug design
inferredcites →https://doi.org/10.1016/j.pnmrs.2007.07.002openalex-snapshot
Ligand- and substrate-based 19F NMR screening: Principles and applications to drug discovery
inferredcites →https://doi.org/10.1016/j.pnmrs.2013.02.001openalex-snapshot
Using chemical shift perturbation to characterise ligand binding
inferredcites →https://doi.org/10.1016/j.tibs.2009.07.004openalex-snapshot
Observing biological dynamics at atomic resolution using NMR
inferredcites →https://doi.org/10.1016/s0079-6565(02)00049-3openalex-snapshot
NMR screening techniques in drug discovery and drug design
inferredcites →https://doi.org/10.1016/s0092-8674(00)81683-9openalex-snapshot
The Hallmarks of Cancer
inferredcites →https://doi.org/10.1016/s0169-409x(96)00423-1openalex-snapshot
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
inferredcites →https://doi.org/10.1016/s0960-894x(01)00031-2openalex-snapshot
Biaryl Ether Retrohydroxamates as Potent, Long-lived, Orally Bioavailable MMP Inhibitors
inferredcites →https://doi.org/10.1016/s1359-6446(03)02831-9openalex-snapshot
A ‘Rule of Three’ for fragment-based lead discovery?
inferredcites →https://doi.org/10.1016/s1359-6446(04)03069-7openalex-snapshot
Ligand efficiency: a useful metric for lead selection
inferredcites →https://doi.org/10.1016/s1359-6446(05)03386-6openalex-snapshot
Ligand efficiency indices as guideposts for drug discovery
inferredcites →https://doi.org/10.1016/s1359-6446(05)03666-4openalex-snapshot
The druggable genome: an update
inferredcites →https://doi.org/10.1016/s1470-2045(10)70261-8openalex-snapshot
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
inferredcites →https://doi.org/10.1016/s1471-4914(02)02295-5openalex-snapshot
Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents
inferredcites →https://doi.org/10.1017/s0033583500005266openalex-snapshot
NMR studies of enzymatic ratesin vitroandin vivoby magnetization transfer
inferredcites →https://doi.org/10.1021/acs.accounts.9b00377openalex-snapshot
SAR by (Protein-Observed) 19F NMR
inferredcites →https://doi.org/10.1021/acs.inorgchem.8b01632openalex-snapshot
Metal-Binding Isosteres as New Scaffolds for Metalloenzyme Inhibitors
inferredcites →https://doi.org/10.1021/acs.jmedchem.0c00120openalex-snapshot
Hybrid Screening Approach for Very Small Fragments: X-ray and Computational Screening on FKBP51
inferredcites →https://doi.org/10.1021/acs.jmedchem.5b01447openalex-snapshot
Protein-Observed Fluorine NMR: A Bioorthogonal Approach for Small Molecule Discovery
inferredcites →https://doi.org/10.1021/acs.jmedchem.5b01583openalex-snapshot
Ligand–Protein Affinity Studies Using Long-Lived States of Fluorine-19 Nuclei
inferredcites →https://doi.org/10.1021/acs.jmedchem.5b01719openalex-snapshot
Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain
inferredcites →https://doi.org/10.1021/acs.jmedchem.5b01940openalex-snapshot
Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination
inferredcites →https://doi.org/10.1021/acs.jmedchem.5b01980openalex-snapshot
Identifying Interactions that Determine Fragment Binding at Protein Hotspots
inferredcites →https://doi.org/10.1021/acs.jmedchem.6b00197openalex-snapshot
Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia
inferredcites →https://doi.org/10.1021/acs.jmedchem.7b00845openalex-snapshot
Direct NMR Probing of Hydration Shells of Protein Ligand Interfaces and Its Application to Drug Design
inferredcites →https://doi.org/10.1021/acs.jmedchem.7b01293openalex-snapshot
Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques
inferredcites →https://doi.org/10.1021/acs.jmedchem.8b00040openalex-snapshot
Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design
inferredcites →https://doi.org/10.1021/acs.jmedchem.8b01210openalex-snapshot
Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects
inferredcites →https://doi.org/10.1021/acschembio.6b00730openalex-snapshot
Protein-Observed Fluorine NMR Is a Complementary Ligand Discovery Method to 1H CPMG Ligand-Observed NMR
inferredcites →https://doi.org/10.1021/acsmedchemlett.9b00235openalex-snapshot
The Dark Side of Fluorine
inferredcites →https://doi.org/10.1021/cc800122mopenalex-snapshot
Estimating Protein−Ligand Binding Affinity Using High-Throughput Screening by NMR
inferredcites →https://doi.org/10.1021/ci000403iopenalex-snapshot
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
inferredcites →https://doi.org/10.1021/ci300355popenalex-snapshot
In Silico Deconstruction of ATP-Competitive Inhibitors of Glycogen Synthase Kinase-3β
inferredcites →https://doi.org/10.1021/ci4000163openalex-snapshot
In Silico Fragment-Based Drug Discovery: Setup and Validation of a Fragment-to-Lead Computational Protocol Using S4MPLE
inferredcites →https://doi.org/10.1021/ja00187a050openalex-snapshot
Studies of protein hydration in aqueous solution by direct NMR observation of individual protein-bound water molecules
inferredcites →https://doi.org/10.1021/ja00763a042openalex-snapshot
Effects of paramagnetic lanthanide shift reagents on the proton magnetic resonance spectra of quinoline and pyridine
inferredcites →https://doi.org/10.1021/ja00766a064openalex-snapshot
Localization of tyrosine at the binding site of neurophysin II by negative nuclear Overhouser effects
inferredcites →https://doi.org/10.1021/ja0100120openalex-snapshot
Group Epitope Mapping by Saturation Transfer Difference NMR To Identify Segments of a Ligand in Direct Contact with a Protein Receptor
inferredcites →https://doi.org/10.1021/ja034646dopenalex-snapshot
Fluorine-NMR Experiments for High-Throughput Screening: Theoretical Aspects, Practical Considerations, and Range of Applicability
inferredcites →https://doi.org/10.1021/ja101837nopenalex-snapshot
Binding or Bending: Distinction of Allosteric Abl Kinase Agonists from Antagonists by an NMR-Based Conformational Assay
inferredcites →https://doi.org/10.1021/ja110571ropenalex-snapshot
Fragment Growing Induces Conformational Changes in Acetylcholine-Binding Protein: A Structural and Thermodynamic Analysis
inferredcites →https://doi.org/10.1021/ja401323mopenalex-snapshot
Small-Molecule Binding Sites on Proteins Established by Paramagnetic NMR Spectroscopy
inferredcites →https://doi.org/10.1021/ja905207topenalex-snapshot
Design and NMR-Based Screening of LEF, a Library of Chemical Fragments with Different Local Environment of Fluorine
inferredcites →https://doi.org/10.1021/ja9702778openalex-snapshot
Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR
inferredcites →https://doi.org/10.1021/ja9702780openalex-snapshot
Stromelysin Inhibitors Designed from Weakly Bound Fragments: Effects of Linking and Cooperativity
inferredcites →https://doi.org/10.1021/ja990706xopenalex-snapshot
Detecting Binding Affinity to Immobilized Receptor Proteins in Compound Libraries by HR-MAS STD NMR
inferredcites →https://doi.org/10.1021/jm000373aopenalex-snapshot
Design of Adenosine Kinase Inhibitors from the NMR-Based Screening of Fragments
inferredcites →https://doi.org/10.1021/jm0103920openalex-snapshot
Phenoxyphenyl Sulfone N -Formylhydroxylamines (Retrohydroxamates) as Potent, Selective, Orally Bioavailable Matrix Metalloproteinase Inhibitors
inferredcites →https://doi.org/10.1021/jm010533yopenalex-snapshot
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
inferredcites →https://doi.org/10.1021/jm020160gopenalex-snapshot
NMR-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability
inferredcites →https://doi.org/10.1021/jm0507532openalex-snapshot
Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x L from NMR and Parallel Synthesis
inferredcites →https://doi.org/10.1021/jm060511hopenalex-snapshot
Fragment-Based Drug Design: How Big Is Too Big?
inferredcites →https://doi.org/10.1021/jm200826sopenalex-snapshot
SAR by Interligand Nuclear Overhauser Effects (ILOEs) Based Discovery of Acylsulfonamide Compounds Active against Bcl-x L and Mcl-1
inferredcites →https://doi.org/10.1021/jm201347kopenalex-snapshot
Automated Protein–Ligand Interaction Screening by Mass Spectrometry
inferredcites →https://doi.org/10.1021/jm301448popenalex-snapshot
Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design
inferredcites →https://doi.org/10.1021/jm301603nopenalex-snapshot
Incorporation of Rapid Thermodynamic Data in Fragment-Based Drug Discovery
inferredcites →https://doi.org/10.1021/jm501660topenalex-snapshot
Small Molecule Binding Sites on the Ras:SOS Complex Can Be Exploited for Inhibition of Ras Activation
inferredcites →https://doi.org/10.1021/jm501984fopenalex-snapshot
Discovery of Tricyclic Indoles That Potently Inhibit Mcl-1 Using Fragment-Based Methods and Structure-Based Design
inferredcites →https://doi.org/10.1021/jm800669sopenalex-snapshot
Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins
inferredcites →https://doi.org/10.1021/jm990194xopenalex-snapshot
Mapping the Active Site of Angiotensin-Converting Enzyme by Transferred NOE Spectroscopy
inferredcites →https://doi.org/10.1023/a:1008354229396openalex-snapshot
Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water*
inferredcites →https://doi.org/10.1038/335440a0openalex-snapshot
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
inferredcites →https://doi.org/10.1038/384641a0openalex-snapshot
The CBP co-activator is a histone acetyltransferase
inferredcites →https://doi.org/10.1038/aps.2016.19openalex-snapshot
NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds
inferredcites →https://doi.org/10.1038/nature03579openalex-snapshot
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
inferredcites →https://doi.org/10.1038/nature08822openalex-snapshot
The landscape of somatic copy-number alteration across human cancers
inferredcites →https://doi.org/10.1038/nature24006openalex-snapshot
USP7 small-molecule inhibitors interfere with ubiquitin binding
inferredcites →https://doi.org/10.1038/ng0697-161openalex-snapshot
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
inferredcites →https://doi.org/10.1038/nm.3048openalex-snapshot
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
inferredcites →https://doi.org/10.1038/nprot.2013.130openalex-snapshot
A three-stage biophysical screening cascade for fragment-based drug discovery
inferredcites →https://doi.org/10.1038/nprot.2016.079openalex-snapshot
Protein-observed 19F-NMR for fragment screening, affinity quantification and druggability assessment
inferredcites →https://doi.org/10.1038/nrc.2017.36openalex-snapshot
Drugging the 'undruggable' cancer targets
inferredcites →https://doi.org/10.1038/nrc883openalex-snapshot
The Bcl2 family: regulators of the cellular life-or-death switch
inferredcites →https://doi.org/10.1038/nrd.2016.109openalex-snapshot
Twenty years on: the impact of fragments on drug discovery
inferredcites →https://doi.org/10.1038/nrd.2016.256openalex-snapshot
Marked for death: targeting epigenetic changes in cancer
inferredcites →https://doi.org/10.1038/nrd3368openalex-snapshot
Impact of high-throughput screening in biomedical research
inferredcites →https://doi.org/10.1038/nrd3926-c1openalex-snapshot
The 'rule of three' for fragment-based drug discovery: where are we now?
inferredcites →https://doi.org/10.1038/onc.2011.443openalex-snapshot
Deubiquitinases in cancer: new functions and therapeutic options
inferredcites →https://doi.org/10.1038/sj.cdd.4402072openalex-snapshot
Bax and the mitochondrial permeability transition cooperate in the release of cytochrome c during endoplasmic reticulum-stress-induced apoptosis
inferredcites →https://doi.org/10.1038/sj.onc.1210166openalex-snapshot
‘Seed’ analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737
inferredcites →https://doi.org/10.1038/srep00257openalex-snapshot
Bak Conformational Changes Induced by Ligand Binding: Insight into BH3 Domain Binding and Bak Homo-Oligomerization
inferredcites →https://doi.org/10.1039/c5ob01508aopenalex-snapshot
Investigations into the binding of jadomycin DS to human topoisomerase IIβ by WaterLOGSY NMR spectroscopy
inferredcites →https://doi.org/10.1039/c9sc05586jopenalex-snapshot
Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery
inferredcites →https://doi.org/10.1042/ebc20170028openalex-snapshot
Current perspectives in fragment-based lead discovery (FBLD)
inferredcites →https://doi.org/10.1054/bjoc.2001.1850openalex-snapshot
Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions
inferredcites →https://doi.org/10.1063/1.1716296openalex-snapshot
Modified Spin-Echo Method for Measuring Nuclear Relaxation Times
inferredcites →https://doi.org/10.1073/pnas.1116510109openalex-snapshot
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
inferredcites →https://doi.org/10.1073/pnas.1904529116openalex-snapshot
Drugging an undruggable pocket on KRAS
inferredcites →https://doi.org/10.1073/pnas.78.7.4046openalex-snapshot
On the attribution and additivity of binding energies
inferredcites →https://doi.org/10.1080/17460441.2019.1583643openalex-snapshot
A bright future for fragment-based drug discovery: what does it hold?
inferredcites →https://doi.org/10.1084/jem.186.3.439openalex-snapshot
Disruption of the Bcl6 Gene Results in an Impaired Germinal Center Formation
inferredcites →https://doi.org/10.1103/physrev.94.630openalex-snapshot
Effects of Diffusion on Free Precession in Nuclear Magnetic Resonance Experiments
inferredcites →https://doi.org/10.1111/his.14009openalex-snapshot
Targeted therapies in gynaecological cancers
inferredcites →https://doi.org/10.1126/science.274.5292.1531openalex-snapshot
Discovering High-Affinity Ligands for Proteins: SAR by NMR
inferredcites →https://doi.org/10.1146/annurev-biochem-060310-170328openalex-snapshot
The Ubiquitin Code
inferredcites →https://doi.org/10.1158/0008-5472.can-11-2612openalex-snapshot
A Comprehensive Survey of Ras Mutations in Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-16-2071openalex-snapshot
The Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target
inferredcites →https://doi.org/10.1172/jci85795openalex-snapshot
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma
inferredcites →https://doi.org/10.1177/1087057110375614openalex-snapshot
Target Immobilization as a Strategy for NMR-Based Fragment Screening: Comparison of TINS, STD, and SPR for Fragment Hit Identification
inferredcites →https://doi.org/10.1200/jco.2011.34.7898openalex-snapshot
Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
inferredcites →https://doi.org/10.1351/pac200173091429openalex-snapshot
NMR spectroscopy in drug design
inferredcites →https://doi.org/10.1371/journal.pcbi.1000435openalex-snapshot
Computational Fragment-Based Binding Site Identification by Ligand Competitive Saturation
inferredcites →https://doi.org/10.1515/revac.1999.18.1-2.23openalex-snapshot
Diffusion Coefficient Measurement by High Resolution NMR Spectroscopy: Biochemical and Pharmaceutical Applications
inferredcites →https://doi.org/10.1517/13543776.11.1.133openalex-snapshot
Sulfone reverse hydroxamates as matrix metalloproteinase inhibitors
inferredcites →https://doi.org/10.1517/13543776.8.3.259openalex-snapshot
Matrix metalloproteinase inhibitors 1998
inferredcites →https://doi.org/10.1517/13543776.9.11.1575openalex-snapshot
Reverse hydroxamate derivatives as metalloprotease inhibitors
inferredcites →https://doi.org/10.15406/mojbb.2017.04.00062openalex-snapshot
Using Fragment Based Drug Discovery to Target Epigenetic Regulators in Cancer
inferredcites →https://doi.org/10.21037/gs.2019.10.18openalex-snapshot
Novel treatments for anaplastic thyroid carcinoma
inferredcites →https://doi.org/10.2174/092986710793348545openalex-snapshot
False Positives in the Early Stages of Drug Discovery
inferredcites →https://doi.org/10.2174/1386207023329923openalex-snapshot
Fluorine-NMR Competition Binding Experiments for High-Throughput Screening of Large Compound Mixtures
inferredcites →https://doi.org/10.2174/1568009054064615openalex-snapshot
Matrix Metalloproteinase Inhibitors as Anticancer Therapeutics
inferredcites →https://doi.org/10.2174/1568026043388015openalex-snapshot
The Evolution of the Matrix Metalloproteinase Inhibitor Drug Discovery Program at Abbott Laboratories
inferredcites →https://doi.org/10.2174/1568026619666181130134250openalex-snapshot
Counting on Fragment Based Drug Design Approach for Drug Discovery
inferredcites →https://doi.org/10.2174/1573406415666190621094704openalex-snapshot
p53: An Attractive Therapeutic Target for Cancer
inferredcites →https://doi.org/10.3109/10428194.2014.981172openalex-snapshot
ABT-199, a BH3 mimetic that specifically targets Bcl-2, enhances the antitumor activity of chemotherapy, bortezomib and JQ1 in “double hit” lymphoma cells
inferredcites →https://doi.org/10.3109/14756366.2016.1161620openalex-snapshot
Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs
inferredcites →https://doi.org/10.3389/fchem.2020.00093openalex-snapshot
In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
inferredcites →https://doi.org/10.3389/fneur.2015.00197openalex-snapshot
A Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System Targets
inferredcites →https://doi.org/10.3389/fphar.2018.01300openalex-snapshot
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
inferredcites →https://doi.org/10.3390/molecules21070860openalex-snapshot
Applications of 19F-NMR in Fragment-Based Drug Discovery
inferredcites →https://doi.org/10.3390/molecules21080984openalex-snapshot
Native Mass Spectrometry in Fragment-Based Drug Discovery
inferredcites →https://doi.org/10.3390/molecules24122337openalex-snapshot
Unraveling Sugar Binding Modes to DC-SIGN by Employing Fluorinated Carbohydrates
inferredcites →https://doi.org/10.3390/molecules24234309openalex-snapshot
Concepts and Core Principles of Fragment-Based Drug Design
inferredcites →https://doi.org/10.3390/molecules25132974openalex-snapshot
A Practical Perspective on the Roles of Solution NMR Spectroscopy in Drug Discovery
inferredcites →https://doi.org/10.4155/fmc-2019-0307openalex-snapshot
An Overview of Drug Discovery and Development
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/ardp.202300612openalex-snapshot
Extracting binding energies and binding modes from biomolecular simulations of fragment binding to endothiapepsin
inferred← citeshttps://doi.org/10.1002/chem.202402820openalex-snapshot
Fluorine Labeling and 19F NMR Spectroscopy to Study Biological Molecules and Molecular Complexes
inferred← citeshttps://doi.org/10.1007/16833_2024_235openalex-snapshot
In Silico and Biophysical Techniques in Anticancer Drug Discovery Research
inferred← citeshttps://doi.org/10.1007/s00216-021-03700-1openalex-snapshot
Lysine reactivity profiling reveals molecular insights into human serum albumin–small-molecule drug interactions
inferred← citeshttps://doi.org/10.1016/j.bmc.2025.118329openalex-snapshot
Structural insights for peptide and small molecules based drug discovery targeting the KEAP1 Kelch domain: A review
inferred← citeshttps://doi.org/10.1016/j.tips.2021.06.001openalex-snapshot
Screening strategies for identifying RNA- and ribonucleoprotein-targeted compounds
inferred← citeshttps://doi.org/10.1016/j.xcrm.2024.101555openalex-snapshot
Advancements in clinical RNA therapeutics: Present developments and prospective outlooks
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c02389openalex-snapshot
Perspectives on Nuclear Magnetic Resonance Spectroscopy in Drug Discovery Research
inferred← citeshttps://doi.org/10.1039/d1cc01778kopenalex-snapshot
Rh-Catalyzed cascade C–H activation/C–C cleavage/cyclization of carboxylic acids with cyclopropanols
inferred← citeshttps://doi.org/10.1039/d2md00170eopenalex-snapshot
19 F chemical library and 19 F-NMR for a weakly bound complex structure
inferred← citeshttps://doi.org/10.1080/1061186x.2024.2427185openalex-snapshot
Drug screening approaches for small-molecule compounds in cancer-targeted therapy
inferred← citeshttps://doi.org/10.1080/17460441.2026.2623154openalex-snapshot
The expectations of in silico fragment-based drug design and future challenges
inferred← citeshttps://doi.org/10.1080/17568919.2025.2533061openalex-snapshot
Overcoming translational barriers in RNA–protein docking: enhancing computational accuracy for targeted drug discovery
inferred← citeshttps://doi.org/10.1371/journal.pone.0257623openalex-snapshot
Fucosyltransferase 2 inhibitors: Identification via docking and STD-NMR studies
inferred← citeshttps://doi.org/10.1515/9783111628240-022openalex-snapshot
45318 NMR spectroscopy: molecular structure decoding
inferred← citeshttps://doi.org/10.21248/gups.83174openalex-snapshot
Cotranscriptional folding and fragment-based drug discovery of regulatory mRNA
inferred← citeshttps://doi.org/10.2174/1568026623666230718100541openalex-snapshot
Current Fragment-to-lead Approaches Starting from the 7-azaindole: The Pharmacological Versatility of a Privileged Molecular Fragment
inferred← citeshttps://doi.org/10.2174/1871520622666220623103957openalex-snapshot
Design, Synthesis and Biological Evaluation of Novel Quinoline Derivatives as Potential Anti-Proliferative Agents Against PC-3 and KG-1 Cells
inferred← citeshttps://doi.org/10.61919/jhrr.v4i1.446openalex-snapshot
In Silico Exploration of APOE4 Inhibitors: Molecular Docking and ADMET Profiling for Alzheimer's Therapy
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.